Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG ) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale. Aditxt, Inc. (NASDAQ: ADTX ) shares climbed 50% to close at $0.24 on Friday after the company''s Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. Waitr Holdings Inc. (NASDAQ: WTRH ) gained 48.5% to settle at $0.35 after the company announced a new partnership with Burq to allow deliveries from several new retail industries. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) surged 44.4% to close at $8.20. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD ) jumped 42.1% to close at $4.25 after gaining 9% on Thursday. Kura Sushi USA, Inc. (NASDAQ: KRUS ) climbed 33.6% to close at $72.29 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG ) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale. Aditxt, Inc. (NASDAQ: ADTX ) shares climbed 50% to close at $0.24 on Friday after the company''s Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. Waitr Holdings Inc. (NASDAQ: WTRH ) gained 48.5% to settle at $0.35 after the company announced a new partnership with Burq to allow deliveries from several new retail industries. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) surged 44.4% to close at $8.20. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD ) jumped 42.1% to close at $4.25 after gaining 9% on Thursday. Kura Sushi USA, Inc. (NASDAQ: KRUS ) climbed 33.6% to close at $72.29 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.